Literature DB >> 12506122

Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1.

Kailesh Gopalbhai1, Gregor Jansen, Geneviève Beauregard, Malcolm Whiteway, France Dumas, Cunle Wu, Sylvain Meloche.   

Abstract

The MAPKKs MEK1 and MEK2 are activated by phosphorylation, but little is known about how these enzymes are inactivated. Here, we show that MEK1 is phosphorylated in vivo at Ser(212), a residue conserved among all MAPKK family members. Mutation of Ser(212) to alanine enhanced the basal activity of MEK1, whereas the phosphomimetic aspartate mutation completely suppressed the activation of both wild-type MEK1 and the constitutively activated MEK1(S218D/S222D) mutant. Phosphorylation of Ser(212) did not interfere with activating phosphorylation of MEK1 at Ser(218)/Ser(222) or with binding to ERK2 substrate. Importantly, mimicking phosphorylation of the equivalent Ser(212) residue of the yeast MAPKKs Pbs2p and Ste7p similarly abrogated their biological function. Our findings suggest that Ser(212) phosphorylation represents an evolutionarily conserved mechanism involved in the negative regulation of MAPKKs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12506122     DOI: 10.1074/jbc.M211870200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.

Authors:  Xinling Zhang; Leina Ma; Jieqiong Qi; Hui Shan; Wengong Yu; Yuchao Gu
Journal:  Mol Cell Biochem       Date:  2015-08-29       Impact factor: 3.396

2.  MAPK target networks in Arabidopsis thaliana revealed using functional protein microarrays.

Authors:  Sorina C Popescu; George V Popescu; Shawn Bachan; Zimei Zhang; Mark Gerstein; Michael Snyder; Savithramma P Dinesh-Kumar
Journal:  Genes Dev       Date:  2008-12-18       Impact factor: 11.361

3.  Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain.

Authors:  Tara C Tassin; David R Benavides; Florian Plattner; Akinori Nishi; James A Bibb
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

4.  Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA.

Authors:  Andrea Marranci; Romina D'Aurizio; Sebastian Vencken; Serena Mero; Elena Guzzolino; Milena Rizzo; Letizia Pitto; Marco Pellegrini; Giovanna Chiorino; Catherine M Greene; Laura Poliseno
Journal:  RNA Biol       Date:  2019-04-19       Impact factor: 4.652

5.  Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations.

Authors:  Matthew J Lazzara; Keara Lane; Richard Chan; Paul J Jasper; Michael B Yaffe; Peter K Sorger; Tyler Jacks; Benjamin G Neel; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

6.  Rice mitogen-activated protein kinase interactome analysis using the yeast two-hybrid system.

Authors:  Raksha Singh; Mi-Ok Lee; Jae-Eun Lee; Jihyun Choi; Ji Hun Park; Eun Hye Kim; Ran Hee Yoo; Jung-Il Cho; Jong-Seong Jeon; Randeep Rakwal; Ganesh Kumar Agrawal; Jae Sun Moon; Nam-Soo Jwa
Journal:  Plant Physiol       Date:  2012-07-11       Impact factor: 8.340

7.  Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer.

Authors:  Abigail E Witt; Lisa M Hines; Nicole L Collins; Yanhui Hu; Ruwanthi N Gunawardane; Donna Moreira; Jacob Raphael; Daniel Jepson; Malvika Koundinya; Andreas Rolfs; Barbara Taron; Steven J Isakoff; Joan S Brugge; Joshua LaBaer
Journal:  J Proteome Res       Date:  2006-03       Impact factor: 4.466

8.  Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.

Authors:  Georgia Hatzivassiliou; Jacob R Haling; Huifen Chen; Kyung Song; Steve Price; Robert Heald; Joanne F M Hewitt; Mark Zak; Ariana Peck; Christine Orr; Mark Merchant; Klaus P Hoeflich; Jocelyn Chan; Shiuh-Ming Luoh; Daniel J Anderson; Mary J C Ludlam; Christian Wiesmann; Mark Ultsch; Lori S Friedman; Shiva Malek; Marcia Belvin
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

9.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

10.  LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome.

Authors:  Kuan-Yu Lai; Sébastien R G Galan; Yibo Zeng; Tianhui Hina Zhou; Chang He; Ritu Raj; Jitka Riedl; Shi Liu; K Phin Chooi; Neha Garg; Min Zeng; Lyn H Jones; Graham J Hutchings; Shabaz Mohammed; Satish K Nair; Jie Chen; Benjamin G Davis; Wilfred A van der Donk
Journal:  Cell       Date:  2021-04-30       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.